Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NL83139.078.22 | Other Identifier | CCMO |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Stichting Wetenschappelijk Onderzoek Het Oogziekenhuis Prof.dr H.J. Flieringa | UNKNOWN |
| Carl Zeiss Meditec AG | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Rationale: In cataract surgery, fragmentation of a hard nucleus requires relatively much ultrasound energy. It is suspected that the level of energy used is associated with the degree of corneal endothelial loss. Recently, it was demonstrated that with miLOOP (Zeiss Meditec) assisted nuclear fragmentation ultrasound energy can be substantially reduced.
Objective: To compare miLOOP assisted cataract surgery and conventional surgery with respect to the energy needed for phacoemulsification and loss of corneal endothelial cells.
Study design: Randomized, controlled trial. Study population: Patients with nuclear cataract of a grade ≥ 5. Intervention: Microinterventional endocapsular nuclear fragmentation. Main study parameters: Cumulative dispersed ultrasound energy (CDE) and endothelial cell loss.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lens fragmentation with miLOOP | Experimental | Phacoemulsification with adjunctive lens fragmentation with the microinterventional microfilament loop device (miLOOP) |
|
| Controls | No Intervention | Phacoemulsification alone (no adjunctive lens fragmentation) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lens fragmentation | Device | Lens fragmentation with the microinterventional microfilament loop device (miLOOP) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Ultrasound cumulative dispersed energy (CDE) | Phaco energy (Centurion, Alcon) | During surgery |
| Change of corneal endothelial cell density (ECD) | Central cell density will be assessed | Preoperative and at 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Procedure time | Total sugery time | During surgery |
| Peri-operative complications | Any complications during surgery | During surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Rene Wubbels | Contact | +31104023430 | r.wubbels@oogziekenhuis.nl | |
| Susan Marinissen | Contact | +31104023449 | S.Marinissen@oogziekenhuis.nl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Oogziekenhuis Rotterdam | Recruiting | Rotterdam | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Postoperative complications | Any complications after surgery | Up to 3 months |